BBP vs IBB

Virtus Biotech ETF against iShares Biotechnology ETF: cost, size, returns, what they hold and how much of it is the same.

Overlap by weight
32%
48 shared positions
Fee gap
10 bp
BBP is cheaper
1-year return gap
9.3 pts
BBP is ahead
Larger fund
IBB
$10.8B

Side by side

BBPIBB
FundVirtus Biotech ETFiShares Biotechnology ETF
IssuerVirtusiShares
CategoryBiotech & Health InnovationBiotech & Health Innovation
Expense ratio0.34%0.44%
Assets$131M$10.8B
Average daily dollar volume$1.4M$343M
ListedDec 16, 2014Feb 5, 2001
FrenzyCap score6683
1-month return+1.2%+1.9%
3-month return+6.8%+8.9%
Year to date+31.1%+22.4%
1-year return+45.2%+35.9%
30-day volatility26.2%23.0%
Worst drawdown, 1 year−9.4%−9.7%
Trailing 12-month yield—0.17%
Holdings63248
Top 10 weight25.5%49.9%
Look-through P/E——
Holdings vs fair value+6.8%−0.0%
Holdings above 200-day average54%77%
Net flow, latest 3 reported months+$32M thru Jul 2026−$43M thru Jun 2026
30-day implied volatility27.8%24.1%
Holdings as ofas of Apr 30, 2026SEC filingas of Oct 8, 2026issuer data

Returns are price returns and exclude distributions. Flows are each fund's own latest reported months and may not cover the same period.

Largest shared holdings

79% of BBP · 60% of IBB
HoldingBBPIBB
MRNA2.49%5.30%
AMGN1.74%7.89%
BIIB1.74%2.36%
GILD1.73%8.37%
UTHR1.84%1.63%
INCY1.59%1.67%
REGN1.52%5.40%
VRTX1.51%7.70%
ONC1.48%2.17%
ALNY1.24%2.21%
INSM1.10%1.59%
NBIX1.38%1.05%
EXEL1.74%1.04%
ASND1.66%1.01%
HALO1.63%0.91%
BBIO1.51%0.84%
BMRN1.61%0.77%
MDGL1.44%0.76%
BNTX1.74%0.65%
KRYS1.71%0.63%
ARWR1.67%0.59%
AXSM2.24%0.55%
IONS1.48%0.52%
RYTM1.14%0.44%
IOVA2.44%0.39%

Sector mix of the stock holdings

SectorBBPIBBGap
Health Care92.5%95.1%−2.6%
Technology0.0%4.7%−4.7%
Materials0.0%0.0%−0.0%

More: full overlap table · BBP holdings · IBB holdings

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.